Abrdn Life Sciences Investors
Abrdn Life Sciences Investors scores highest on Torque (93) and lowest on Nitro (28). Its PosiPenta is 67.98 out of 100, better than most similar companies.
Compared with similar companies in the Financial Services sector in United States.
The five pillars
Details
PPrice
| P/E ratio | 2.67 |
| P/B ratio | 0.96 |
EEarnings
| Trailing EPS | ₹629.35 |
| Forward EPS | — |
NNitro
| Price | 1680.49 |
| 52-week high | 2148.71 |
| 52-week low | 1484.29 |
| Fall from 52-week high | 21.8% |
TTorque
| Return on equity (ROE) | 41.42% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.73 |
| Market cap | ₹5,110 Cr |
| Insider holding | 0.00% |
| Dividend yield | 12.48% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Abrdn Life Sciences Investors' PosiPenta score?
Abrdn Life Sciences Investors' PosiPenta is 67.98 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for Abrdn Life Sciences Investors?
Torque (durability), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Abrdn Life Sciences Investors?
Nitro (momentum), with a score of 28 out of 100: weaker than most similar companies.
Has Abrdn Life Sciences Investors' PosiPenta changed since last week?
Yes, it rose 0.89 points, from 67.09 to 67.98.
PositoAI is for research and education only and is not investment advice.